Apim Therapeutics

APIM Therapeutics AS

This clinical-stage biotechnology company develops peptide drugs targeting cellular stress responses to treat patients with advanced solid tumours and multiple cancers.

Pep-Therapy

This biotechnology company develops intracellular peptide-based targeted therapies to treat patients with advanced solid tumours, including pancreatic and ovarian cancers.

Aprea Therapeutics

This company develops targeted cancer therapies for patients with biomarker-defined tumours and DNA damage response pathway defects.

Apoxis SA

This company develops therapeutic proteins and small molecules for the treatment of cancer and inflammatory diseases in clinical-stage patients.

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Oncopeptides AB

This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.

Ariceum Therapeutics

This clinical-stage biotechnology company develops targeted radiopharmaceutical therapies for the diagnosis and treatment of aggressive, hard-to-treat cancers.

Aprit

Aprit Biotech develops targeted alpha-particle radio-immunotherapy drugs for the treatment of ovarian cancer patients.